Sort
261,768 grants matching “gene therapy”
Accelerate Clinical Trials in CMT (ACTCMT) Study
$1,258,621David N Herrmann · University Of Rochester · U01 · FY2022 · NS
Innovation through collaboration at the intersection of childhood development and cancer: a platform for the Gabriella Miller Kids First Pediatric Data Resource Center
$1,258,582Adam Cain Resnick · Children'S Hosp Of Philadelphia · U2C · FY2017 · HL
Editing Alveolar Progenitor Cells for Correction of Monogenic Disease
$1,258,327Jeffrey A Whitsett · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · HL
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,258,277Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,258,255Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION IN HUMAN LEUKEMIA
$1,258,167Paul Liu · National Human Genome Research Institute · ZIA · FY2012 · HG
Brittle Bone Disorders Consortium of the Rare Disease Clinical Research Network
$1,258,097Brendan Hl Lee · Baylor College Of Medicine · U54 · FY2014 · AR
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma
$1,258,062Geoffrey L Chupp · Yale University · UH3 · FY2016 · HL
RCMI@Morgan: Center for Urban Health Disparities Research and Innovation
$1,257,794James M Wachira · Morgan State University · U54 · FY2019 · MD
Comparative Modeling: Informing Breast Cancer Control Practice & Policy
$1,257,743Jeanne Mandelblatt · Georgetown University · U01 · FY2010 · CA
Human Genes Affecting Chromosome Metabolism and Stress Response
$1,257,687Daniel Menendez · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Structure and function of eukaryotic DNA transposases
$1,257,643Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Human Monoclonal Antibodies and Antibody-Guided Nanoparticles
$1,257,527Dimiter S Dimitrov · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Clinical Pharmacogenetics
$1,257,271William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Leveraging prenatal tolerance to improve AAV/bNAb therapy outcomes in infancy
$1,257,182Mauricio De Aguiar Martins · University Of Florida · U01 · FY2025 · AI
Metabolic Studies of Mouse Models of Obesity and Diabetes
$1,257,077Oksana Gavrilova · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2022 · DK
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,257,077Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2025 · AI
SPORE in Skin Cancer
$1,256,837Wistar Institute · P50 · FY2001 · CA
Control of centrosome biogenesis
$1,256,812Jadranka Loncarek · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Genomic Diversity of Prostate Cancer Across the African Diaspora
$1,256,800Timothy R Rebbeck · Dana-Farber Cancer Inst · R01 · FY2024 · CA
WU-SN-TMC Bio-Analysis Core
$1,256,356Feng Chen · Washington University · U54 · FY2022 · AG
AAV-mediated delivery of the inflammasome adapter protein, ASC, as a pro-apoptotic gene therapy for schwannoma
$1,256,291Na Nora Yang · Merlin Therapeutics Inc · R44 · FY2025 · NS
Genetic and Neuronal Mechanisms that Regulate Zebrafish Sleep
$1,256,250David Aaron Prober · California Institute Of Technology · R35 · FY2023 · NS
Genetic and Neuronal Mechanisms that Regulate Zebrafish Sleep
$1,256,250David Aaron Prober · California Institute Of Technology · R35 · FY2022 · NS
Preclinical Development of Novel Rickettsiosis Therapeutics Targeting EPAC1
$1,256,218Xiaodong Cheng · University Of Texas Hlth Sci Ctr Houston · R01 · FY2016 · AI